Skip to main content
OpenTrials
Completed

NCT Number: NCT06783985

Clinical Application of Carbon Nanoparticles in Lymph Node Tracing and Surgery Guiding of Colorectal Cancer

This trial aims to clarify the relationship between carbon nanoparticles labeled lymph nodes and lymph node metastasis in different lymph node regions of colorectal cancer, and to clarify the application value of carbon nanoparticles in lymph node dissection in colorectal cancer surgery.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Sir Run Run Shaw hospital

Hangzhou, Zhejiang, China

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • a diagnosis of colorectal cancer;
  • endoscopic injection of CNP suspension preoperatively
  • planned radical resection of colorectal cancer
  • older than 18 years of age

Exclusion criteria

(a) emergency surgery;

Treatment and study plan

Primary outcomes

  1. The relationship between carbon nanoparticle stained lymph nodes and metastatic lymph nodes

    Time frame: From enrollment to the pathology report at 2 weeks

Secondary outcomes

  1. Carbon nanoparticle stained lymph nodes from different lymph node groups.

    Time frame: From enrollment to the pathology report at 2 weeks

Sponsors and collaborators

Lead sponsor

Sir Run Run Shaw Hospital

Other

Registry information

Acronym: CNP-CRC

Important dates

Study start
2022
Primary completion
2024
Study completion
2024
First posted
Jan 20, 2025
Registry last updated
Jan 20, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.